Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
29.96
-0.51 (-1.67%)
At close: Aug 31, 2026, 4:00 PM EDT
29.96
0.00 (0.00%)
After-hours: Aug 31, 2026, 6:30 PM EDT
Oscar Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 15,041 | 11,470 | 8,971 | 5,686 | 3,871 | 1,886 |
Total Interest & Dividend Income | 248.23 | 202.94 | 185.73 | 155.45 | 27.59 | 2.3 |
Other Revenue | 29.58 | 28.59 | 20.58 | 21.35 | 64.93 | 5.39 |
| 15,319 | 11,701 | 9,178 | 5,863 | 3,964 | 1,894 | |
Revenue Growth | 42.82% | 27.50% | 56.54% | 47.92% | 109.27% | 384.43% |
Policy Benefits | 12,231 | 10,019 | 7,333 | 4,642 | 3,281 | 1,624 |
Depreciation & Amortization | 28.27 | 28.89 | 32.15 | 30.69 | 15.28 | - |
Selling, General & Administrative | 2,430 | 2,050 | 1,756 | 1,426 | 1,257 | 360.16 |
Other Operating Expenses | - | - | - | - | - | 368.07 |
Total Operating Expenses | 14,689 | 12,098 | 9,120 | 6,098 | 4,554 | 2,439 |
Operating Income | 629.72 | -396.36 | 57.27 | -235.62 | -589.87 | -544.48 |
Interest Expense | -15.85 | -17.6 | -23.73 | -24.6 | -22.62 | -4.72 |
Other Non Operating Income (Expenses) | -24.06 | -23.34 | -0.11 | -7.08 | 2.42 | -1.2 |
EBT Excluding Unusual Items | 589.81 | -437.3 | 33.43 | -267.3 | -610.08 | -550.4 |
Other Unusual Items | - | - | - | - | - | -20.18 |
Pretax Income | 589.81 | -437.3 | 33.43 | -267.3 | -610.08 | -570.58 |
Income Tax Expense | 38.88 | 5.61 | 7.31 | 3.29 | -0.52 | 0.85 |
Earnings From Continuing Ops. | 550.93 | -442.9 | 26.12 | -270.59 | -609.55 | -571.43 |
Minority Interest in Earnings | -0.19 | -0.25 | -0.69 | -0.13 | 3.28 | -1.18 |
Net Income | 550.74 | -443.15 | 25.43 | -270.73 | -606.28 | -572.61 |
Net Income to Common | 550.74 | -443.15 | 25.43 | -270.73 | -606.28 | -572.61 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 286 | 262 | 240 | 222 | 212 | 179 |
Shares Outstanding (Diluted) | 293 | 262 | 266 | 222 | 212 | 179 |
Shares Change | 17.37% | -1.30% | 19.94% | 4.32% | 18.72% | 511.57% |
EPS (Basic) | 1.93 | -1.69 | 0.11 | -1.22 | -2.85 | -3.20 |
EPS (Diluted) | 1.91 | -1.69 | 0.10 | -1.22 | -2.85 | -3.20 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4,380 | 1,058 | 950.3 | -297.74 | 351.34 | -207.63 |
Free Cash Flow Per Share | 14.95 | 4.03 | 3.58 | -1.34 | 1.65 | -1.16 |
Operating Margin | 4.11% | -3.39% | 0.62% | -4.02% | -14.88% | -28.75% |
Profit Margin | 3.60% | -3.79% | 0.28% | -4.62% | -15.30% | -30.23% |
Free Cash Flow Margin | 28.59% | 9.05% | 10.36% | -5.08% | 8.86% | -10.96% |
EBITDA | 657.96 | -367.47 | 89.41 | -204.92 | -574.58 | -529.88 |
EBITDA Margin | 4.29% | -3.14% | 0.97% | -3.50% | -14.50% | -27.98% |
D&A For EBITDA | 28.24 | 28.89 | 32.15 | 30.69 | 15.28 | 14.61 |
EBIT | 629.72 | -396.36 | 57.27 | -235.62 | -589.87 | -544.48 |
EBIT Margin | 4.11% | -3.39% | 0.62% | -4.02% | -14.88% | -28.75% |
Effective Tax Rate | 6.59% | - | 21.85% | - | - | - |
Revenue as Reported | 15,319 | 11,701 | 9,178 | 5,863 | 3,964 | - |